1 Unstoppable Dividend Stock to Buy and Hold for a Decade

Shares have fallen roughly 20% YTD to about $300, but American Express reported 2025 revenue up 10% to $72.2B and adjusted EPS of $15.38 (up 15%), with Q4 revenue +10% to $19.0B and EPS +16%. Billed business rose 9% to $445.1B, management authorized a 16% quarterly dividend increase to $0.95 ($3.80 annualized, ~1.3% yield, <25% payout ratio), and the company returned $7.6B to shareholders in 2025 including $5.3B of buybacks (reducing share count ~2%). Shares trade near ~17x the midpoint of 2026 guidance ($17.30–$17.90), presenting an attractive valuation for investors focused on pricing power, cash returns, and durable consumer spend exposure.

Analysis

American Express's combination of premium-product pricing and cohort migration to younger, higher-engagement customers is a multi-year compounder in unit economics — small increases in retention or spend per member amplify NPV because incremental marketing cost per account falls as acquisition scale builds. Coupled with recurring buybacks that mechanically shrink float, a steady margin on transaction fees converts behavioral wins into outsized per-share results; replicate the ~2% annual shrinkage in float for 3 years and EPS leverage becomes non-linear versus peers.

Second-order winners include lifestyle platforms integrated into AmEx perks (reservation networks, high-end travel suppliers and digital concierge partners) which capture more of the wallet as AmEx monetizes credits and booking flows; merchants that lean into premium consumers (luxury hotels, premium dining) should see higher AOVs and conversion. Conversely, merchant acquirers and low-cost card networks—especially those competing on interchange-sensitive SMB segments—could benefit if some merchants push back on AmEx fees, accelerating routing to Visa/Mastercard or fee-negotiated acceptance, creating pressure on AmEx’s merchant economics over a multi-quarter window.

Key risks are macro-driven (discretionary spend contraction or a credit-cycle uptick that raises loss rates) and regulatory (interchange scrutiny or mandated routing changes); either could remove the premium multiple quickly. Near-term trade catalysts are quarterly guidance cadence and travel seasonality; medium-term upside depends on cohort LTV maturation and continued buyback authorization. Time-horizon framing: days—positioning and flows; months—earnings and guidance; years—cohort monetization and net-share-count effects.

Key Decisions for Investors

• Buy AXP equity (entry < $320): target $360–$420 in 12–24 months (20–40% upside). Hard stop at $240 (≈20% downside from entry) to protect against credit-cycle shocks; position size 2–4% NAV.
• Directional options: buy AXP Jan 2028 $325 LEAP calls and finance by selling 6–9 month $380 calls (calendar-funded long); use as 1.5–2x directional exposure with capped near-term cost and participation in multi-year cohort LTV compounding.
• Relative-value pair: long AXP / short MA (equal-dollar) for 12 months to express idiosyncratic pricing-power and buyback optionality vs secular network growth; expect 15–25% relative outperformance if AmEx sustains premium pricing—tighten if spread reverses by 5%.
• Income/entry plan: sell cash-secured 6–9 month AXP $250 puts sized to potential purchase allocation; if assigned, effective cost basis falls materially and generates income while collecting premiums to shorten payback on entry.